Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Checkpoint Inhibitor PD-1H/VISTA Functions As MMP-13 Receptor on Osteoclasts and Mediates MMP-13 Induced Osteoclast Activation in Multiple Myeloma

Jing Fu, PhD, Shirong Li, PhD, Chen Yang, Lewis M Brown, PhD, Stephen J Weiss, MD PhD, Charles G Drake, MD PhD, Markus Y. Mapara, MD PhD, Suzanne Lentzsch, MD PhD

Blood (2019) 134 (Supplement_1): 3072.

https://doi.org/10.1182/blood-2019-129177

Published: 2019

Journal Articles

Gone baby gone—but how?

Charles G. Drake

Blood (2012) 120 (24): 4664–4666.

https://doi.org/10.1182/blood-2012-10-459099

Published: 2012

Journal Articles

A 2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells

Paul E. Zarek, Ching-Tai Huang, Eric R. Lutz, Jeanne Kowalski, Maureen R. Horton, Joel Linden, Charles G. Drake, Jonathan D. Powell

Blood (2008) 111 (1): 251–259.

https://doi.org/10.1182/blood-2007-03-081646

Published: 2008

Includes: Supplemental data

Journal Articles

STAT3 Signaling in Donor-Derived CD4 + T-Cells Plays a Critical Role in the Induction of Acute and Chronic GVHD in Murine Models of alloBMT.

Vedran Radojcic, MD, Maria A. Pletneva, BSc, Hung-Rong Yen, MD, Timothy J. Harris, Bsc, Drew M. Pardoll, MD, PhD, Charles G. Drake, MD, PhD, Leo Luznik, MD

Blood (2007) 110 (11): 2179.

https://doi.org/10.1182/blood.V110.11.2179.2179

Published: 2007

Journal Articles

Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells

Monica V. Goldberg, Charles H. Maris, Edward L. Hipkiss, Andrew S. Flies, Lijie Zhen, Rubin M. Tuder, Joseph F. Grosso, Timothy J. Harris, Derese Getnet, Katharine A. Whartenby, Dirk G. Brockstedt, Thomas W. Dubensky, Jr, Lieping Chen, Drew M. Pardoll, Charles G. Drake

Blood (2007) 110 (1): 186–192.

https://doi.org/10.1182/blood-2006-12-062422

Published: 2007

Journal Articles

Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines

Gang Zhou, Charles G. Drake, Hyam I. Levitsky

Blood (2006) 107 (2): 628–636.

https://doi.org/10.1182/blood-2005-07-2737

Published: 2006

NARROW

Checkpoint Inhibitor PD-1H/VISTA Functions As MMP-13 Receptor on Osteoclasts and Mediates MMP-13 Induced Osteoclast Activation in Multiple Myeloma

Gone baby gone—but how?

A 2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells

STAT3 Signaling in Donor-Derived CD4 + T-Cells Plays a Critical Role in the Induction of Acute and Chronic GVHD in Murine Models of alloBMT.

Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells

Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines

Email alerts

ASH Publications

American Society of Hematology

Checkpoint Inhibitor PD-1H/VISTA Functions As MMP-13 Receptor on Osteoclasts and Mediates MMP-13 Induced Osteoclast Activation in Multiple Myeloma

Gone baby gone—but how?

A 2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells

STAT3 Signaling in Donor-Derived CD4 + T-Cells Plays a Critical Role in the Induction of Acute and Chronic GVHD in Murine Models of alloBMT.

Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells

Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only